In fact, immunohistochemical analysis on 279 NSCLC cases indicated that elevated EphA2 expression was associated with K-Ras mutations, EGFR activation, smoking history and poor prognosis[29]. Here, EPHA2 is linked to non-small cell lung carcinoma.